Resmed Inc. buy Morgan Stanley
Start price
27.10.23
/
50%
€126.35
Target price
27.10.24
€160.06
Performance (%)
89.47%
End price
28.10.24
€239.40
Summary
This prediction ended on 28.10.24 with a price of €239.40. The BUY prediction by Morgan_Stanley for Resmed Inc. saw massive gains of 89.47%. Morgan_Stanley has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. A total of €1.82 was paid as dividends for this prediction. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 1.496% | 1.496% | -20.235% |
| iShares Core DAX® | 0,88 % | 5,63 % | 8,48 % |
| iShares Nasdaq 100 | 2,39 % | 1,57 % | 28,41 % |
| iShares Nikkei 225® | 4,27 % | 2,52 % | 50,98 % |
| iShares S&P 500 | 1,17 % | 2,55 % | 23,60 % |
Comments by Morgan_Stanley for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $169.00 price target on the stock, down previously from $180.00.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten